Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trials. - Benedetti DJ; Cost NG; Ehrlich PF; Evageliou N; Fialkowski E; Parsons LN; Vallance KL; Renfro LA; Hong AL; Aldrink JH; Pater L; Paulino AC; et al. (Nature reviews. Urology, 2025)